Authors: Emma Riis Skarsø1,2, Lasse Hindhede Refsgaard3,2, Abhilasha Saini4, Ebbe Laugaard Lorenzen5, Else Maae6, Esben Yates7, Ingelise Jensen8, Karen Andersen9, Kristian Boye10, Louise Wichmann Matthiessen9, Maja Maraldo10, Martin Berg6, Mette Holck Nielsen11, Mette Møller8, Sami Aziz-Jowad Al-Rawi4, Birgitte Offersen3,7,1,2, Stine Sofia Korreman7,1,2
1Aarhus University Hospital, Danish Center for Particle Therapy, Aarhus, Denmark; 2Aarhus University, Department of Clinical medicine, Aarhus, Denmark; 3Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus, Denmark; 4Zealand University Hospital, Department of Clinical Oncology and Palliative Care, Næstved, Denmark; 5Odense University Hospital, Laboratory of Radiation Physics, Odense, Denmark; 6Vejle Hospital, University Hospital of Southern Denmark, Department of Oncology, Vejle, Denmark; 7Aarhus University Hospital, Department of Oncology, Aarhus, Denmark; 8Aalborg University Hospital, Department of Oncology, Aalborg, Denmark; 9Herlev and Gentofte Hospital, Department of Oncology, Herlev, Denmark; 10Copenhagen University Hospital – Rigshospitalet, Department of Oncology, Copenhagen, Denmark; 11Odense University Hospital, Department of Oncology, Odense, Denmark